These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 37017412)

  • 1. The effect of hydroxychloroquine on pregnancy outcomes in patients with unexplained recurrent pregnancy loss: a placebo-controlled study "pilot study".
    Moini A; Sepidarkish M; Dehpour AR; Rabiei M; Abiri A; Pirjani R
    J Obstet Gynaecol; 2022 Nov; 42(8):3471-3476. PubMed ID: 37017412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant human granulocyte- colony stimulating factor in women with unexplained recurrent pregnancy losses: a randomized clinical trial.
    Eapen A; Joing M; Kwon P; Tong J; Maneta E; De Santo C; Mussai F; Lissauer D; Carter D;
    Hum Reprod; 2019 Mar; 34(3):424-432. PubMed ID: 30776296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydroxychloroquine for prevention of recurrent miscarriage: study protocol for a multicentre randomised placebo-controlled trial BBQ study.
    Pasquier E; de Saint-Martin L; Marhic G; Chauleur C; Bohec C; Bretelle F; Lejeune-Saada V; Hannigsberg J; Plu-Bureau G; Cogulet V; Merviel P; Mottier D
    BMJ Open; 2019 Mar; 9(3):e025649. PubMed ID: 30898821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydroxychloroquine efficacy and safety in preventing SARS-CoV-2 infection and COVID-19 disease severity during pregnancy (COVID-Preg): a structured summary of a study protocol for a randomised placebo controlled trial.
    González R; García-Otero L; Pons-Duran C; Marbán-Castro E; Goncé A; Llurba E; Gil MDM; Rodríguez-Zambrano MÁ; Chen H; Ramírez M; Bardají A; Menendez C
    Trials; 2020 Jul; 21(1):607. PubMed ID: 32616063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydroxychloroquine in the treatment of adult patients with Covid-19 infection in a primary care setting (LIBERTY): A structured summary of a study protocol for a randomised controlled trial.
    Vainio PJ; Hietasalo P; Koivisto AL; Kääriäinen S; Turunen J; Virtala M; Vuorinen J; Scheinin M
    Trials; 2021 Jan; 22(1):44. PubMed ID: 33430933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chinese herbal medicines for unexplained recurrent miscarriage.
    Li L; Dou L; Leung PC; Chung TK; Wang CC
    Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD010568. PubMed ID: 26760986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PROMISE: first-trimester progesterone therapy in women with a history of unexplained recurrent miscarriages - a randomised, double-blind, placebo-controlled, international multicentre trial and economic evaluation.
    Coomarasamy A; Williams H; Truchanowicz E; Seed PT; Small R; Quenby S; Gupta P; Dawood F; Koot YE; Atik RB; Bloemenkamp KW; Brady R; Briley A; Cavallaro R; Cheong YC; Chu J; Eapen A; Essex H; Ewies A; Hoek A; Kaaijk EM; Koks CA; Li TC; MacLean M; Mol BW; Moore J; Parrott S; Ross JA; Sharpe L; Stewart J; Trépel D; Vaithilingam N; Farquharson RG; Kilby MD; Khalaf Y; Goddijn M; Regan L; Rai R
    Health Technol Assess; 2016 May; 20(41):1-92. PubMed ID: 27225013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chloroquine or hydroxychloroquine for prevention and treatment of COVID-19.
    Singh B; Ryan H; Kredo T; Chaplin M; Fletcher T
    Cochrane Database Syst Rev; 2021 Feb; 2(2):CD013587. PubMed ID: 33624299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ChemoPROphyLaxIs with hydroxychloroquine For covId-19 infeCtious disease (PROLIFIC) to prevent covid-19 infection in frontline healthcare workers: A structured summary of a study protocol for a randomised controlled trial.
    McEniery CM; Fisk M; Miles K; Kaloyirou F; Hubsch A; Smith J; Wilkinson IB; Cheriyan J
    Trials; 2020 Jul; 21(1):604. PubMed ID: 32616067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time to conception and time to live birth in women with unexplained recurrent miscarriage.
    Kaandorp SP; van Mens TE; Middeldorp S; Hutten BA; Hof MH; van der Post JA; van der Veen F; Goddijn M
    Hum Reprod; 2014 Jun; 29(6):1146-52. PubMed ID: 24682612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-visualized pregnancy losses are prognostically important for unexplained recurrent miscarriage.
    Kolte AM; van Oppenraaij RH; Quenby S; Farquharson RG; Stephenson M; Goddijn M; Christiansen OB;
    Hum Reprod; 2014 May; 29(5):931-7. PubMed ID: 24603132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial.
    Cuadrado-Lavín A; Olmos JM; Cifrian JM; Gimenez T; Gandarillas MA; García-Saiz M; Rebollo MH; Martínez-Taboada V; López-Hoyos M; Fariñas MC; Crespo J
    Trials; 2020 Jun; 21(1):472. PubMed ID: 32493494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progestogens for preventing miscarriage: a network meta-analysis.
    Devall AJ; Papadopoulou A; Podesek M; Haas DM; Price MJ; Coomarasamy A; Gallos ID
    Cochrane Database Syst Rev; 2021 Apr; 4(4):CD013792. PubMed ID: 33872382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood CD4
    Liao J; Li Y; Li X; Su X; Peng J; Xiao N; Fan X; Chen H; Lu G; Lin G; Cheng L; Gong F
    Int Immunopharmacol; 2022 Sep; 110():108960. PubMed ID: 35759810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of unexplained recurrent spontaneous abortion using intravenous immunoglobulin: a prospective, randomized, double-blinded, placebo-controlled trial.
    Stephenson MD; Dreher K; Houlihan E; Wu V
    Am J Reprod Immunol; 1998 Feb; 39(2):82-8. PubMed ID: 9506206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mononuclear-cell immunisation in prevention of recurrent miscarriages: a randomised trial.
    Ober C; Karrison T; Odem RR; Barnes RB; Branch DW; Stephenson MD; Baron B; Walker MA; Scott JR; Schreiber JR
    Lancet; 1999 Jul; 354(9176):365-9. PubMed ID: 10437864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progestogen for preventing miscarriage in women with recurrent miscarriage of unclear etiology.
    Haas DM; Hathaway TJ; Ramsey PS
    Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31745982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of hydroxychloroquine for post-exposure prophylaxis to prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among adults exposed to coronavirus disease (COVID-19): a structured summary of a study protocol for a randomised controlled trial.
    Barnabas RV; Brown E; Bershteyn A; Miller RS; Wener M; Celum C; Wald A; Chu H; Wesche D; Baeten JM;
    Trials; 2020 Jun; 21(1):475. PubMed ID: 32493478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized controlled phase 2 trial of hydroxychloroquine in childhood interstitial lung disease.
    Griese M; Kappler M; Stehling F; Schulze J; Baden W; Koerner-Rettberg C; Carlens J; Prenzel F; Nährlich L; Thalmeier A; Sebah D; Kronfeld K; Rock H; Ruckes C; ; Wetzke M; Seidl E; Schwerk N
    Orphanet J Rare Dis; 2022 Jul; 17(1):289. PubMed ID: 35871071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.